Clinical Trials
4 trialsNCT03025256 2026-05-05
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05305365 2025-12-23
Study Assessing QBS72S For Treating Brain Metastases
Stanford University
Phase 2 Active not recruiting
NCT05257967 2025-02-11
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease
British Columbia Cancer Agency
Phase NA Recruiting
NCT03711422 2022-06-14
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
National Cancer Centre, Singapore
Phase 1 Terminated